Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phosphorus-containing replacement fluid to prevent and treat CRRT-associated hypophosphatemia
ChiCTR2100046884Phase 4Recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium glycerophosphate in acute kidney failure (AKF) (2 arms), sponsored by Xinqiao Hospital. Primary endpoint: Incidence of hypophosphatemia. Started Dec 2019; status: recruiting.
02
Drugs
sodium glycerophosphate
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ChiCTR2100046884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046884.